Literature DB >> 28758826

Implication of sphingosine-1-phosphate signaling in diseases: molecular mechanism and therapeutic strategies.

Mohd Arish1, Mohammed Alaidarous2, Rahat Ali1, Yusuf Akhter3, Abdur Rub1,2.   

Abstract

Sphingosine-1-phosphate signaling is emerging as a critical regulator of cellular processes that is initiated by the intracellular production of bioactive lipid molecule, sphingosine-1-phosphate. Binding of sphingosine-1-phosphate to its extracellular receptors activates diverse downstream signaling that play a critical role in governing physiological processes. Increasing evidence suggests that this signaling pathway often gets impaired during pathophysiological and diseased conditions and hence manipulation of this signaling pathway may be beneficial in providing treatment. In this review, we summarized the recent findings of S1P signaling pathway and the versatile role of the participating candidates in context with several disease conditions. Finally, we discussed its possible role as a novel drug target in different diseases.

Entities:  

Keywords:  Sphingosine-1-phosphate receptor; cancer; drug target; microbial diseases; signaling; sphingosine kinase; targeting S1P signaling

Mesh:

Substances:

Year:  2017        PMID: 28758826     DOI: 10.1080/10799893.2017.1358282

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  8 in total

1.  Functional contribution of sphingosine-1-phosphate to airway pathology in cigarette smoke-exposed mice.

Authors:  Giovanna De Cunto; Vincenzo Brancaleone; Maria Antonietta Riemma; Ida Cerqua; Valentina Vellecco; Giuseppe Spaziano; Eleonora Cavarra; Barbara Bartalesi; Bruno D'Agostino; Giuseppe Lungarella; Giuseppe Cirino; Monica Lucattelli; Fiorentina Roviezzo
Journal:  Br J Pharmacol       Date:  2019-11-06       Impact factor: 8.739

2.  Sphingosine-1-phosphate signaling in Leishmania donovani infection in macrophages.

Authors:  Mohd Arish; Atahar Husein; Rahat Ali; Shams Tabrez; Farha Naz; Mohammad Zulfazal Ahmad; Abdur Rub
Journal:  PLoS Negl Trop Dis       Date:  2018-08-17

Review 3.  Signaling through the S1P-S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment.

Authors:  Simela Chatzikonstantinou; Vasiliki Poulidou; Marianthi Arnaoutoglou; Dimitrios Kazis; Ioannis Heliopoulos; Nikolaos Grigoriadis; Marina Boziki
Journal:  Cells       Date:  2021-11-18       Impact factor: 6.600

Review 4.  Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives.

Authors:  Gary Álvarez Bravo; René Robles Cedeño; Marc Puig Casadevall; Lluís Ramió-Torrentà
Journal:  Cells       Date:  2022-06-29       Impact factor: 7.666

5.  Enzymatic independent role of sphingosine kinase 2 in regulating the expression of type I interferon during influenza A virus infection.

Authors:  Mengqiong Xu; Sisi Xia; Mei Wang; Xiaolian Liu; Xin Li; Weijie Chen; Yaohao Wang; Hongjian Li; Chuan Xia; Jun Chen; Jianguo Wu
Journal:  PLoS Pathog       Date:  2022-09-07       Impact factor: 7.464

6.  Conjugated Bile Acids Promote Invasive Growth of Esophageal Adenocarcinoma Cells and Cancer Stem Cell Expansion via Sphingosine 1-Phosphate Receptor 2-Mediated Yes-Associated Protein Activation.

Authors:  Runping Liu; Xiaojiaoyang Li; Phillip B Hylemon; Huiping Zhou
Journal:  Am J Pathol       Date:  2018-06-30       Impact factor: 5.770

7.  Identification of sphingosine 1-phosphate level and MAPK/ERK signaling in pancreatic β cells.

Authors:  Ji Hyun Park; Kwan Kyu Park; Jae Young Choe; Kyung Mi Jang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2021-05-17

8.  Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis.

Authors:  Melanie Rinas; Jakob Wirbel; Marti Bernardo-Faura; Inna Pertsovskaya; Vicky Pliaka; Dimitris E Messinis; Gemma Vila; Theodore Sakellaropoulos; Wolfgang Faigle; Pernilla Stridh; Janina R Behrens; Tomas Olsson; Roland Martin; Friedemann Paul; Leonidas G Alexopoulos; Pablo Villoslada; Julio Saez-Rodriguez
Journal:  Genome Med       Date:  2021-07-16       Impact factor: 11.117

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.